Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINI-Lifestyle Cohort
- PMID: 33408047
- DOI: 10.1016/j.euf.2020.12.005
Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINI-Lifestyle Cohort
Abstract
Background: Dietary agents, in particular vitamin D (Vit D) and selenium, are widely used by prostate cancer (PCa) patients to improve cancer outcomes.
Objective: To investigate whether plasma Vit D and selenium levels prior to radical prostatectomy (RP) are associated with worse pathologic tumor characteristics and increased risk of disease recurrence.
Design, setting, and participants: A total of 3849 men with PCa scheduled for RP in the Martini-Klinik at the University Hospital Hamburg-Eppendorf, Hamburg, Germany, between January 2014 and December 2018 were included in this study.
Outcome measurements and statistical analysis: Age, and clinical and laboratory values were collected prior to RP. Biochemical recurrence (BCR) was defined as prostate-specific antigen (PSA) ≥0.2 μg/l and rising after RP. Kaplan-Meier plots depicted BCR-free survival. Cox regression models (adjusted for age, preoperative PSA, pT stage, pN stage, pGG, surgical margin status, and year of surgery) tested the relationship between oncologic outcomes and Vit D and selenium levels.
Results and limitations: Median plasma Vit D and selenium levels were 19.3 and 71 μg/l, respectively. Circulating Vit D and selenium levels correlated inversely with PSA values. Histologic grade, pT stage, and pN stage were not associated with Vit D and selenium levels at the time of RP. In the overall cohort, BCR-free survival at 3 yr of follow-up was 82.9%. When stratified according to median Vit D levels, BCR-free survival at 3 yr of follow-up was 82.7% and 83.0% (p ≤ 0.59). Upon stratification according to median selenium levels, BCR-free survival was 82.2% and 83.7% (p = 0.19). In a multivariable Cox regression model predicting BCR, lower Vit D and selenium levels were not independent predictors of BCR.
Conclusions: Plasma Vit D and selenium levels prior to RP were not associated with BCR-free survival.
Patient summary: The results of the MARTINI-Lifestyle cohort could not show a correlation between the occurrence of biochemical recurrence of prostate cancer after radical prostatectomy and the serum levels of vitamin D and selenium. A recommendation should therefore be made to compensate for a potential deficiency and not with the expectation of a reduction in the risk of progression.
Keywords: Prostate cancer; Recurrence; Selenium; Tumor characteristics; Vitamin D.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval.Eur Urol Oncol. 2025 Apr;8(2):372-379. doi: 10.1016/j.euo.2024.08.008. Epub 2024 Sep 20. Eur Urol Oncol. 2025. PMID: 39306583
-
Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.Eur Urol. 2015 Sep;68(3):497-505. doi: 10.1016/j.eururo.2015.06.020. Epub 2015 Jun 26. Eur Urol. 2015. PMID: 26119559
-
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.Eur Urol. 2016 Apr;69(4):728-733. doi: 10.1016/j.eururo.2015.10.009. Epub 2015 Oct 21. Eur Urol. 2016. PMID: 26497924
-
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer.Cancer Treat Rev. 2024 Jan;122:102630. doi: 10.1016/j.ctrv.2023.102630. Epub 2023 Sep 27. Cancer Treat Rev. 2024. PMID: 38035646 Review.
-
High-Dose Vitamin C for Cancer Therapy.Pharmaceuticals (Basel). 2022 Jun 3;15(6):711. doi: 10.3390/ph15060711. Pharmaceuticals (Basel). 2022. PMID: 35745630 Free PMC article. Review.
Cited by
-
[Cardiovascular side effects in patients undergoing androgen deprivation therapy: superiority of gonadotropin-releasing hormone antagonists? An update].Urologe A. 2021 Nov;60(11):1450-1457. doi: 10.1007/s00120-021-01583-9. Epub 2021 Jul 2. Urologe A. 2021. PMID: 34213627 Free PMC article. Review. German.
-
Association of Vitamin D and Prostate Health Status in Men: An Analytical Cross-Sectional Study.Cureus. 2024 Dec 2;16(12):e74959. doi: 10.7759/cureus.74959. eCollection 2024 Dec. Cureus. 2024. PMID: 39744261 Free PMC article.
-
Association of Plasma Selenium and Its Untargeted Metabolomic Profiling with Cervical Cancer Prognosis.Biol Trace Elem Res. 2023 Oct;201(10):4637-4648. doi: 10.1007/s12011-022-03552-5. Epub 2023 Jan 7. Biol Trace Elem Res. 2023. PMID: 36609649
-
Possible impact of antioxidant intake on composite dietary antioxidant index and the progression of benign prostatic hyperplasia: an observational study.BMC Public Health. 2024 Dec 18;24(1):3524. doi: 10.1186/s12889-024-21098-0. BMC Public Health. 2024. PMID: 39695528 Free PMC article.
-
Possible non-linear relation between prostate specific antigen and vitamin D: a machine learning study based on cross-section data.J Cancer. 2024 May 13;15(11):3625-3632. doi: 10.7150/jca.96052. eCollection 2024. J Cancer. 2024. PMID: 38817878 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous